ProQR Therapeutics NV banner

ProQR Therapeutics NV
NASDAQ:PRQR

Watchlist Manager
ProQR Therapeutics NV Logo
ProQR Therapeutics NV
NASDAQ:PRQR
Watchlist
Price: 1.8 USD -4.76% Market Closed
Market Cap: $189.6m

Wall Street
Price Targets

PRQR Price Targets Summary
ProQR Therapeutics NV

Wall Street analysts forecast PRQR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRQR is 9.18 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.

Lowest
Price Target
4.04 USD
124% Upside
Average
Price Target
9.18 USD
410% Upside
Highest
Price Target
14.7 USD
717% Upside
ProQR Therapeutics NV Competitors:
Price Targets
NYXH
Nyxoah SA
223% Upside
LINC
Lincoln Educational Services Corp
-6% Downside
QXO
SilverSun Technologies Inc
52% Upside
HOTH
Hoth Therapeutics Inc
407% Upside
IBEX
Ibex Ltd
43% Upside

Revenue
Forecast

59% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
59% / Year
Past Growth
40% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 11 years the compound annual growth rate for ProQR Therapeutics NV's revenue is 59%. The projected CAGR for the next 4 years is 40%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-61%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-61%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRQR's stock price target?
Price Target
9.18 USD

According to Wall Street analysts, the average 1-year price target for PRQR is 9.18 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.

What is ProQR Therapeutics NV's Revenue forecast?
Projected CAGR
40%

For the last 11 years the compound annual growth rate for ProQR Therapeutics NV's revenue is 59%. The projected CAGR for the next 4 years is 40%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett